HeraMED (ASX:HMD) has raised US$2.8 million via placement and SPP
HeraMED Limited (ASX:HMD) has raised funds to accelerate HearCARE’s commercial roll out and progress ongoing research projects.
HeraMED is a medical technology company leading the digital transformation of maternity care with its proprietary telehealth platform. The company offers a platform that utilizes hardware and software to reshape the doctor/patient relationship using its clinically validated in-home fetal and maternal heart rate monitor, HeraBEAT, cloud computing, artificial intelligence, big data and a digital social networking dashboard.
Oaklins’ team in Australia acted as lead manager in this transaction.
Talk to the deal team
SulAmérica and Rede D’Or São Luiz have announced a combination
SulAmérica (B3:SULA11), a leading insurance company in Brazil, has announced a combination with Rede D’Or São Luiz S.A. (B3:RDOR3), the largest Brazilian hospital network. The companies had a combined market value of approximately US$21 billion on 18 February 2022.Learn more
BRM has been acquired by Alta Resources
The shareholders of BRM have sold the company to Alta Resources, a leading customer relations business process outsourcer.Learn more
Optano, a leading provider of AI-powered operations solutions, acquired by A.T. Kearney
The private shareholders of Optano GmbH have sold the company to A.T. Kearney. Optano will support them on operation engagements, chiefly in AI-powered supply chain projects, and large-scale operation transformations.Learn more